Bluebird Bio - 48 Year Dividend History | BLUE

Historical dividend payout and yield for Bluebird Bio (BLUE) since 1971. The current TTM dividend payout for Bluebird Bio (BLUE) as of June 14, 2019 is $0.00. The current dividend yield for Bluebird Bio as of June 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.486B $0.055B
Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83